The contribution of neuropilin‐1 in the stability of CD4+CD25+ regulatory T cells through the TGF‐β1/Smads signaling pathway in the presence of lipopolysaccharides
Article in Immunity Inflammation and Disease (November 2021)
The most recent citing publications are shown below. View all 24 publications that cite this research output on Dimensions.
Safety, tolerability, and immune-biomarker profiling for year-long sargramostim treatment of Parkinson's disease
Article in EBioMedicine (May 2021)
Targeting Neuropilin-1 Suppresses the Stability of CD4+ CD25+ Regulatory T Cells via the NF-κB Signaling Pathway in Sepsis.
Article in Infection and Immunity (January 2021)